These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19333949)

  • 1. Lack of evidence of stimulatory autoantibodies to platelet-derived growth factor receptor in patients with systemic sclerosis.
    Classen JF; Henrohn D; Rorsman F; Lennartsson J; Lauwerys BR; Wikström G; Rorsman C; Lenglez S; Franck-Larsson K; Tomasi JP; Kämpe O; Vanthuyne M; Houssiau FA; Demoulin JB
    Arthritis Rheum; 2009 Apr; 60(4):1137-44. PubMed ID: 19333949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of detection of agonist activity by antibodies to platelet-derived growth factor receptor alpha in a subset of normal and systemic sclerosis patient sera.
    Loizos N; Lariccia L; Weiner J; Griffith H; Boin F; Hummers L; Wigley F; Kussie P
    Arthritis Rheum; 2009 Apr; 60(4):1145-51. PubMed ID: 19333919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis.
    Baroni SS; Santillo M; Bevilacqua F; Luchetti M; Spadoni T; Mancini M; Fraticelli P; Sambo P; Funaro A; Kazlauskas A; Avvedimento EV; Gabrielli A
    N Engl J Med; 2006 Jun; 354(25):2667-76. PubMed ID: 16790699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope Specificity Determines Pathogenicity and Detectability of Anti-Platelet-Derived Growth Factor Receptor α Autoantibodies in Systemic Sclerosis.
    Moroncini G; Grieco A; Nacci G; Paolini C; Tonnini C; Pozniak KN; Cuccioloni M; Mozzicafreddo M; Svegliati S; Angeletti M; Kazlauskas A; Avvedimento EV; Funaro A; Gabrielli A
    Arthritis Rheumatol; 2015 Jul; 67(7):1891-903. PubMed ID: 25808833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Role of PDGF-A/PDGFR-α in proliferation and transdifferentiation of fibroblasts from skin lesions of patients with systemic sclerosis].
    Liu T; Zhang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2012 Apr; 32(4):496-501. PubMed ID: 22543129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of binding and quantification of human autoantibodies to PDGFRα using a biosensor-based approach.
    Moroncini G; Cuccioloni M; Mozzicafreddo M; Pozniak KN; Grieco A; Paolini C; Tonnini C; Spadoni T; Svegliati S; Funaro A; Angeletti M; Gabrielli A
    Anal Biochem; 2017 Jul; 528():26-33. PubMed ID: 28450104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-PDGFR-alpha antibodies measured by non-bioactivity assays are not specific for systemic sclerosis.
    Balada E; Simeón-Aznar CP; Ordi-Ros J; Rosa-Leyva M; Selva-O'Callaghan A; Pardos-Gea J; Fonollosa-Pla V; Vilardell-Tarrés M
    Ann Rheum Dis; 2008 Jul; 67(7):1027-9. PubMed ID: 18272670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PDGF/PDGFR: A Possible Molecular Target in Scleroderma Fibrosis.
    Paolini C; Agarbati S; Benfaremo D; Mozzicafreddo M; Svegliati S; Moroncini G
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies against platelet-derived growth factor receptor alpha in patients with systemic lupus erythematosus.
    Kurasawa K; Arai S; Owada T; Maezawa R; Kumano K; Fukuda T
    Mod Rheumatol; 2010 Oct; 20(5):458-65. PubMed ID: 20490598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular expression of platelet-derived growth factor (PDGF)-A, -B chain and PDGF receptor-alpha, -beta in human diabetic nephropathy.
    Uehara G; Suzuki D; Toyoda M; Umezono T; Sakai H
    Clin Exp Nephrol; 2004 Mar; 8(1):36-42. PubMed ID: 15067514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agonistic antibodies in systemic sclerosis.
    Moroncini G; Svegliati Baroni S; Gabrielli A
    Immunol Lett; 2018 Mar; 195():83-87. PubMed ID: 29032187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P; Bujak M; Chatila K; Cieslak A; Thakker G; Entman ML; Frangogiannis NG
    J Am Coll Cardiol; 2006 Dec; 48(11):2315-23. PubMed ID: 17161265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor beta deficient mice.
    Basciani S; Mariani S; Arizzi M; Brama M; Ricci A; Betsholtz C; Bondjers C; Ricci G; Catizone A; Galdieri M; Spera G; Gnessi L
    Biol Reprod; 2004 Jan; 70(1):168-77. PubMed ID: 14522834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.
    Kavian N; Servettaz A; Marut W; Nicco C; Chéreau C; Weill B; Batteux F
    Arthritis Rheum; 2012 Jun; 64(6):1990-2000. PubMed ID: 22213155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis immunoglobulin induces growth and a pro-fibrotic state in vascular smooth muscle cells through the epidermal growth factor receptor.
    Arts MR; Baron M; Chokr N; Fritzler MJ; ; Servant MJ
    PLoS One; 2014; 9(6):e100035. PubMed ID: 24927197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Scleroderma Fibrosis in Skin-Humanized Mice by Administration of Anti-Platelet-Derived Growth Factor Receptor Agonistic Autoantibodies.
    Luchetti MM; Moroncini G; Jose Escamez M; Svegliati Baroni S; Spadoni T; Grieco A; Paolini C; Funaro A; Avvedimento EV; Larcher F; Del Rio M; Gabrielli A
    Arthritis Rheumatol; 2016 Sep; 68(9):2263-73. PubMed ID: 27111463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell depletion therapy in patients with diffuse systemic sclerosis associates with a significant decrease in PDGFR expression and activation in spindle-like cells in the skin.
    Daoussis D; Tsamandas AC; Liossis SN; Antonopoulos I; Karatza E; Yiannopoulos G; Andonopoulos AP
    Arthritis Res Ther; 2012 Jun; 14(3):R145. PubMed ID: 22697462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies.
    Shen J; Vil MD; Jimenez X; Zhang H; Iacolina M; Mangalampalli V; Balderes P; Ludwig DL; Zhu Z
    J Immunol Methods; 2007 Jan; 318(1-2):65-74. PubMed ID: 17126853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGF-C and -D and their receptors PDGFR-alpha and PDGFR-beta in atherosclerotic human arteries.
    Karvinen H; Rutanen J; Leppänen O; Lach R; Levonen AL; Eriksson U; Ylä-Herttuala S
    Eur J Clin Invest; 2009 Apr; 39(4):320-7. PubMed ID: 19292888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.